ATE196297T1 - Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung - Google Patents

Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung

Info

Publication number
ATE196297T1
ATE196297T1 AT95918481T AT95918481T ATE196297T1 AT E196297 T1 ATE196297 T1 AT E196297T1 AT 95918481 T AT95918481 T AT 95918481T AT 95918481 T AT95918481 T AT 95918481T AT E196297 T1 ATE196297 T1 AT E196297T1
Authority
AT
Austria
Prior art keywords
heterodimeric
carrier composition
immunogenic polypeptides
subunit
cell antigen
Prior art date
Application number
AT95918481T
Other languages
English (en)
Inventor
Michael E Houston
Nian E Zhou
Cyril M Kay
Robert S Hodges
Paul J Cachia
Randall T Irvin
Original Assignee
Synthetic Peptides Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Peptides Inc filed Critical Synthetic Peptides Inc
Application granted granted Critical
Publication of ATE196297T1 publication Critical patent/ATE196297T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT95918481T 1994-05-18 1995-05-18 Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung ATE196297T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24550794A 1994-05-18 1994-05-18
PCT/CA1995/000293 WO1995031480A1 (en) 1994-05-18 1995-05-18 Heterodimer polypeptide immunogen carrier composition and method

Publications (1)

Publication Number Publication Date
ATE196297T1 true ATE196297T1 (de) 2000-09-15

Family

ID=22926961

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918481T ATE196297T1 (de) 1994-05-18 1995-05-18 Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung

Country Status (7)

Country Link
EP (1) EP0759941B1 (de)
JP (2) JP3872813B2 (de)
AT (1) ATE196297T1 (de)
AU (1) AU708472B2 (de)
CA (1) CA2190494C (de)
DE (1) DE69518838T2 (de)
WO (1) WO1995031480A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854931A4 (de) * 1995-10-06 2002-02-13 Pence Inc Methoden und zusammensetzungen für die detektion und reinigung von exprimierten proteinen über "coild coil heterodimer" wechselwirkungen
WO1997038011A1 (en) * 1996-04-03 1997-10-16 Pepresearch A/S Non-dendritic backbone peptide carrier
US6165335A (en) * 1996-04-25 2000-12-26 Pence And Mcgill University Biosensor device and method
US6130037A (en) * 1996-04-25 2000-10-10 Pence And Mcgill University Biosensor device and method
US6271198B1 (en) 1996-11-06 2001-08-07 Genentech, Inc. Constrained helical peptides and methods of making same
CA2329689A1 (en) 1998-06-12 1999-12-23 The Governors Of The University Of Alberta Composition and method for treatment of pseudomonas
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
AU2898500A (en) 1999-03-02 2000-09-21 Helix Biopharma Corporation Biosensor device and method
HUP0200958A3 (en) 1999-04-23 2004-11-29 Pharmexa As Method for down-regulating il5 activity
US6872806B1 (en) 1999-06-25 2005-03-29 The Governors Of The University Of Alberta Polypeptide compositions formed using a coiled-coil template and methods of use
CA2410604A1 (en) * 2000-06-14 2001-12-20 Cytovax Biotechnologies, Inc. Use of coiled-coil structural scaffold to generate structure-specific peptides
UA81634C2 (ru) 2002-07-18 2008-01-25 Хеликс Биофарма Корп. Фармацевтическая композиция уреазы для ингибирования роста раковых клеток и ее применение
US7264800B2 (en) 2002-07-18 2007-09-04 Helix Biopharma Corporation Method and composition for inhibiting cancer cell growth
CA2543200A1 (en) * 2003-10-24 2005-05-06 National Research Council Of Canada Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
WO2005090388A1 (en) 2004-03-19 2005-09-29 The University Of Queensland Alpha helical mimics, their uses and methods for their production
CA2523032A1 (en) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
WO2009146523A1 (en) 2008-06-05 2009-12-10 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
CN102939101A (zh) 2010-01-26 2013-02-20 科罗拉多大学董事会，法人 用于通用疫苗的流感病毒组合物和方法
MX374963B (es) 2011-04-29 2025-03-06 Selecta Biosciences Inc Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.
CN113876945A (zh) 2011-10-06 2022-01-04 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
WO2013083254A1 (en) 2011-12-09 2013-06-13 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
BR122020023215B1 (pt) 2013-05-03 2022-11-22 Selecta Biosciences, Inc Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico
JP7242180B2 (ja) 2014-09-07 2023-03-20 セレクタ バイオサイエンシーズ インコーポレーテッド 抗ウイルス導入ベクター免疫応答を減弱化するための方法および組成物
ES3036482T3 (en) 2017-03-11 2025-09-19 Cartesian Therapeutics Inc Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
CN112566650A (zh) 2018-06-21 2021-03-26 沙塔克实验室有限公司 异二聚体蛋白及其用途
AU2020287627A1 (en) 2019-06-04 2021-11-18 Selecta Biosciences, Inc. Formulations and doses of PEGylated uricase
US12281161B2 (en) 2021-07-28 2025-04-22 Trustees Of Boston University Polypeptides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015110A1 (en) * 1992-01-31 1993-08-05 Whitehead Institute For Biomedical Research Amino acid sequences which pair specifically

Also Published As

Publication number Publication date
DE69518838T2 (de) 2001-05-03
DE69518838D1 (de) 2000-10-19
CA2190494C (en) 2002-05-07
AU708472B2 (en) 1999-08-05
AU2441895A (en) 1995-12-05
EP0759941B1 (de) 2000-09-13
CA2190494A1 (en) 1995-11-23
JP2006257095A (ja) 2006-09-28
EP0759941A1 (de) 1997-03-05
JP3872813B2 (ja) 2007-01-24
WO1995031480A1 (en) 1995-11-23
JPH10504018A (ja) 1998-04-14

Similar Documents

Publication Publication Date Title
ATE196297T1 (de) Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung
DK1273304T4 (da) Anvendelse af interleukin-15
UA39168C2 (uk) Фторалкоксифенільні похідні піперидину або хінуклідину, що є антагоністами речовини p і фармацевтична композиція на їх основі
ATE196314T1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
AR248133A1 (es) Procedimiento para la preparacion de derivados de amido-3 pirazol.
FI933253A7 (fi) Uusia amyliiniantagonistipeptidejä ja käyttö amyliiniantagonisteina
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
DE3850185D1 (de) Härtbare Verbindungen, deren Herstellung und Verwendung.
IL72082A (en) Cyclic pentapeptides displaying somatostatin antagonism and their preparation
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
EP0253190A3 (en) Partially retro-inverted tuftsin analogues, method for the preparation thereof and pharmaceutical compositions containing them
ZA936970B (en) Anti-feline immunodeficiency virus (FIV) vaccines
DE69228749D1 (de) Neuartige polypeptide und ihre verwendung
TW272197B (de)
DK0783521T3 (da) Polypeptidforbindelser indeholdende D-2-alkyltryptophan, hvilke er i stand til at fremme frigivelsen af væksthormon
IL74147A (en) 2-acylamino-hexahydro-arylquinolizines and salts thereof and pharmaceutical compositions containing them
DE3774779D1 (de) Polymere zusammensetzung und daraus hergestellte schlichte fuer textilmaterialien.
FR2630430B1 (fr) Nouvelles compositions vitreuses luminescentes, leur preparation et leur application
SE8604991L (sv) Tillvexthemmande peptid fran ormgift
IL86710A0 (en) Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same
DE69928947D1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
EE9900566A (xx) Helicobacter pylori FlgE pol�peptiidi sisaldavad vaktsiinikoostised
DE3853710D1 (de) Siliciumatome und Imidogruppen enthaltende Oligomere, härtbare Zusammensetzungen und deren Herstellung.
IT9020295A0 (it) Procedimento di dosaggio di anti-corpi igg anti-allergeni specifici, frazione ricca in ihg4 ottenuta secondo questo procedimento e composizione farmaceutica contenente questa frazione
IL82719A0 (en) Small peptides which inhibit binding to t-4 receptors and act as immunogens and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties